These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 24750386)

  • 41. MiR-21 in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction.
    Miyahara N; Benazzo A; Oberndorfer F; Iwasaki A; Laszlo V; Döme B; Hoda MA; Jaksch P; Klepetko W; Hoetzenecker K
    Transpl Int; 2021; 35():10184. PubMed ID: 35185369
    [No Abstract]   [Full Text] [Related]  

  • 42. Quantitative Image Analysis at Chronic Lung Allograft Dysfunction Onset Predicts Mortality.
    Weigt SS; Kim GJ; Jones HD; Ramsey AL; Amubieya O; Abtin F; Pourzand L; Lee J; Shino MY; DerHovanessian A; Stripp B; Noble PW; Sayah DM; Saggar R; Britton I; Lynch JP; Belperio JA; Goldin J
    Transplantation; 2022 Jun; 106(6):1253-1261. PubMed ID: 34534193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Prognostic Importance of Bronchoalveolar Lavage Fluid CXCL9 During Minimal Acute Rejection on the Risk of Chronic Lung Allograft Dysfunction.
    Shino MY; Weigt SS; Li N; Derhovanessian A; Sayah DM; Saggar R; Huynh RH; Gregson AL; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
    Am J Transplant; 2018 Jan; 18(1):136-144. PubMed ID: 28637080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy.
    Vanaudenaerde BM; Meyts I; Vos R; Geudens N; De Wever W; Verbeken EK; Van Raemdonck DE; Dupont LJ; Verleden GM
    Eur Respir J; 2008 Oct; 32(4):832-43. PubMed ID: 18827151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic lung allograft dysfunction: evolving practice.
    Vos R; Verleden SE; Verleden GM
    Curr Opin Organ Transplant; 2015 Oct; 20(5):483-91. PubMed ID: 26262458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of Allograft Injury Time of Onset on the Development of Chronic Lung Allograft Dysfunction After Lung Transplantation.
    Shino MY; Weigt SS; Li N; Derhovanessian A; Sayah DM; Huynh RH; Saggar R; Gregson AL; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
    Am J Transplant; 2017 May; 17(5):1294-1303. PubMed ID: 27676455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of cytokine expression in the pre-implanted donor lung on the development of chronic lung allograft dysfunction subtypes.
    Saito T; Takahashi H; Kaneda H; Binnie M; Azad S; Sato M; Waddell TK; Cypel M; Liu M; Keshavjee S
    Am J Transplant; 2013 Dec; 13(12):3192-201. PubMed ID: 24164971
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Azithromycin and the treatment of lymphocytic airway inflammation after lung transplantation.
    Vos R; Verleden SE; Ruttens D; Vandermeulen E; Bellon H; Neyrinck A; Van Raemdonck DE; Yserbyt J; Dupont LJ; Verbeken EK; Moelants E; Mortier A; Proost P; Schols D; Cox B; Verleden GM; Vanaudenaerde BM
    Am J Transplant; 2014 Dec; 14(12):2736-48. PubMed ID: 25394537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
    Benden C; Haughton M; Leonard S; Huber LC
    J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The common rejection module in chronic rejection post lung transplantation.
    Sacreas A; Yang JYC; Vanaudenaerde BM; Sigdel TK; Liberto JM; Damm I; Verleden GM; Vos R; Verleden SE; Sarwal MM
    PLoS One; 2018; 13(10):e0205107. PubMed ID: 30289917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The potential of biomarkers of fibrosis in chronic lung allograft dysfunction.
    van der Ploeg EA; Melgert BN; Burgess JK; Gan CT
    Transplant Rev (Orlando); 2021 Jul; 35(3):100626. PubMed ID: 33992914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bronchoalveolar lavage cytokine-based risk stratification of minimal acute rejection in clinically stable lung transplant recipients.
    Levy L; Huszti E; Ahmed M; Ghany R; Hunter S; Moshkelgosha S; Zhang CYK; Boonstra K; Klement W; Tikkanen J; Singer LG; Keshavjee S; Juvet S; Martinu T
    J Heart Lung Transplant; 2021 Dec; 40(12):1540-1549. PubMed ID: 34215500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Azithromycin Partially Mitigates Dysregulated Repair of Lung Allograft Small Airway Epithelium.
    Ling KM; Garratt LW; Banerjee B; Lavender MA; Wrobel JP; Musk M; Martinovich KM; Shaw NC; Iosifidis T; Looi K; Kicic-Starcevich E; Sutanto EN; Yerkovich ST; Chambers DC; Stick SM; Kicic A
    Transplantation; 2020 Jun; 104(6):1166-1176. PubMed ID: 31985728
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involvement of IL-26 in bronchiolitis obliterans syndrome but not in acute rejection after lung transplantation.
    Magnusson JM; Ericson P; Tengvall S; Stockfelt M; Brundin B; Lindén A; Riise GC
    Respir Res; 2022 May; 23(1):108. PubMed ID: 35501858
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relation of sputum neutrophilia to the development of chronic lung allograft dysfunction after lung transplantation.
    Sikkeland LIB; Durheim MT; Riste TB; Kongerud J; Alexis NE; Holm AM
    Clin Transplant; 2021 Mar; 35(3):e14188. PubMed ID: 33315265
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immediate postoperative inflammatory response predicts long-term outcome in lung-transplant recipients.
    Hall DJ; Baz M; Daniels MJ; Staples ED; Klodell CT; Moldawer LL; Beaver TM
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):603-7. PubMed ID: 22815323
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system.
    Levy L; Huszti E; Renaud-Picard B; Berra G; Kawashima M; Takahagi A; Fuchs E; Ghany R; Moshkelgosha S; Keshavjee S; Singer LG; Tikkanen J; Martinu T
    J Heart Lung Transplant; 2020 Aug; 39(8):761-770. PubMed ID: 32418864
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aspiration, localized pulmonary inflammation, and predictors of early-onset bronchiolitis obliterans syndrome after lung transplantation.
    Fisichella PM; Davis CS; Lowery E; Ramirez L; Gamelli RL; Kovacs EJ
    J Am Coll Surg; 2013 Jul; 217(1):90-100; discussion 100-1. PubMed ID: 23628225
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of recipient derived interleukin-17A in a murine orthotopic lung transplant model of restrictive chronic lung allograft dysfunction.
    Yamada Y; Vandermeulen E; Heigl T; Somers J; Vaneylen A; Verleden SE; Bellon H; De Vleeschauwer S; Verbeken EK; Van Raemdonck DE; Vos R; Verleden GM; Jungraithmayr W; Vanaudenaerde BM
    Transpl Immunol; 2016 Nov; 39():10-17. PubMed ID: 27737799
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients.
    Neurohr C; Huppmann P; Samweber B; Leuschner S; Zimmermann G; Leuchte H; Baumgartner R; Hatz R; Frey L; Ueberfuhr P; Bittmann I; Behr J;
    J Heart Lung Transplant; 2009 May; 28(5):468-74. PubMed ID: 19416775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.